ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 84 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $478 | -28.4% | 71,639 | +6.4% | 0.00% | -100.0% |
Q1 2023 | $668 | -99.5% | 67,325 | +115.4% | 0.00% | – |
Q2 2022 | $124,000 | -79.7% | 31,249 | -77.3% | 0.00% | -100.0% |
Q1 2022 | $612,000 | +63.6% | 137,741 | +46.9% | 0.00% | – |
Q4 2021 | $374,000 | +59.1% | 93,739 | +350.5% | 0.00% | – |
Q3 2021 | $235,000 | -0.8% | 20,810 | -0.5% | 0.00% | – |
Q2 2021 | $237,000 | +47.2% | 20,925 | +54.2% | 0.00% | – |
Q1 2021 | $161,000 | +41.2% | 13,566 | -19.0% | 0.00% | – |
Q4 2020 | $114,000 | +1800.0% | 16,747 | +1674.0% | 0.00% | – |
Q3 2020 | $6,000 | +50.0% | 944 | -18.1% | 0.00% | – |
Q2 2020 | $4,000 | -63.6% | 1,153 | -74.5% | 0.00% | – |
Q1 2020 | $11,000 | +266.7% | 4,519 | +677.8% | 0.00% | – |
Q3 2019 | $3,000 | +200.0% | 581 | +270.1% | 0.00% | – |
Q4 2018 | $1,000 | -99.9% | 157 | -99.7% | 0.00% | -100.0% |
Q3 2018 | $810,000 | +3421.7% | 58,745 | +1872.6% | 0.00% | – |
Q2 2018 | $23,000 | +2200.0% | 2,978 | +1389.0% | 0.00% | – |
Q1 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |